Dr. Ricardo Esquitin, MD

Dr. Esquitin practices at White Plains Hospital in White Plains, New York, part of Montefiore Einstein.

Dr. Esquitin's NPI, 1144435033, was assigned on May 14, 2007. Dr. Esquitin graduated from Icahn School Of Medicine At Mount Sinai in 2006. Dr. Esquitin holds New York license 245667.

Dr. Esquitin's primary practice is White Plains Hospital, at Davis Ave at E Post Road, White Plains, NY 10601 in Westchester County. The practice phone is (914) 681-0600. Dr. Esquitin also practices at White Plains Hospital, 41 E Post Rd, White Plains, NY 10601.

Dr. Esquitin's primary practice is White Plains Hospital in White Plains, New York, part of Montefiore Einstein. Dr. Esquitin is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is White Plains Hospital Physician Associates. Dmand AI also links Dr. Esquitin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Esquitin practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Esquitin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Esquitin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Esquitin's licenses on file in 3 states: New York, Massachusetts and Vermont.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Esquitin treats.

CMS data shows 3,183 Medicare services from Dr. Esquitin across 21 procedure codes in 2024, for 1,115 Medicare patients. Medicare paid $175,503 for them.

CMS counts 1,115 Medicare patients who saw Dr. Esquitin in 2024. The largest group is 75 to 84, with 421 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Esquitin's median patient age at 73, with 45% women.

In 2024, Dr. Esquitin wrote 3,201 Medicare Part D claims for 561 patients. 84% of them were for generic drugs. CMS names the drug for 2,997 of them, across 38 drugs with 11 or more claims each, at $631,916 in total drug cost. In 2023, CMS named 2,238 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Esquitin for performance year 2024, reported through an alternative payment model (APM). Dr. Esquitin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Esquitin, published from 2011 to 2013. 2012 was the busiest year, with 2. Dr. Esquitin has published most often in Am J Cardiol. Dr. Esquitin's most frequent co-authors are Michael Farkouh, MD, Louai Razzouk, MD, MPH and Sanjum S. Sethi, MD.

CMS Open Payments shows 630 general payments to Dr. Esquitin from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,281.

Dmand AI lists 2 awards for Dr. Esquitin, most recently Summer Research Scholar in 2001.

Dr. Esquitin graduated from Icahn School Of Medicine At Mount Sinai in 2006. Dr. Esquitin is a member of ACC.

Dr. Esquitin is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.